In this study, univariate analysis revealed that 6 variables significantly increased the risk of RAI-refractory DTC: histopathological aggressive tumour subtype, TNM stage II and above, LVI presence, m-ETE, high AXL expression, and TERT promoter mutation (all p values < 0.05). The gene discussed is AXL; the disease is neoplasm.